About Data I/O Corporation
Since 1972, Data I/O has developed innovative solutions to enable the design and manufacture of electronic products for automotive, Internet-of-Things, medical, wireless, consumer electronics, industrial controls and other electronics devices. Today, our customers use Data I/O’s data programming solutions and security deployment platform to secure the global electronics supply chain and protect IoT device intellectual property from point of inception to deployment in the field. OEMs of any size can program and securely provision devices from early samples all the way to high volume production prior to shipping semiconductor devices to a manufacturing line. Data I/O enables customers to reliably, securely, and cost-effectively bring innovative new products to life. These solutions are backed by a portfolio of patents and a global network of Data I/O support and service professionals, ensuring success for our customers. Learn more at dataio.com/Company/Patents.
Forward Looking Statements, Non-GAAP Financial Measures and Disclaimers
Statements in this news release concerning economic outlook, expected revenue, expected margins, expected savings, expected results, expected expenses, orders, deliveries, backlog and financial positions, semiconductor chip shortages, supply chain expectations, as well as any other statement that may be construed as a prediction of future performance or events are forward-looking statements which involve known and unknown risks, uncertainties and other factors which may cause actual results to differ materially from those expressed or implied by such statements.
Forward-looking statement disclaimers also apply to the global COVID-19 pandemic, including the effects on the Company’s business from Shanghai’s COVID-19 lockdowns and recovery, impact on the demand for the Company’s products, and the Russian invasion of Ukraine including any related international trade restrictions. These factors include uncertainties as to the ability to record revenues based upon the timing of product deliveries, shipping availability, installations and acceptance, accrual of expenses, coronavirus related business interruptions, changes in economic conditions, part shortages and other risks including those described in the Company's filings on Forms 10-K and 10-Q with the Securities and Exchange Commission (SEC), press releases and other communications.
Non-GAAP financial measures, such as EBITDA and Adjusted EBITDA, excluding equity compensation, should not be considered a substitute for, or superior to, measures of financial performance prepared in accordance with GAAP. We believe that these non-GAAP financial measures provide meaningful supplemental information regarding the Company’s results and facilitate the comparison of results.
Participation in the Data I/O Fireside Chat Series is voluntary, and no compensation is provided to guest hosts. Reference made to guest hosts, including equity research analysts and investors, in connection with this announcement and related interviews or any opinions, estimates or forecasts regarding Data I/O’s performance made by them are theirs alone and do not represent opinions, forecasts or predictions of Data I/O or its management. Data I/O does not by its reference above or distribution of marketing content in connection with the Fireside Chat Series imply its endorsement of or concurrence with such information, conclusions or recommendations by the guest hosts.
- tables follow -
DATA I/O CORPORATION CONSOLIDATED STATEMENTS OF OPERATIONS (in thousands, except per share amounts) (UNAUDITED) |
||||||||
Three Months Ended
|
|
Nine Months Ended
|
||||||
2023 |
|
2022 |
|
2023 |
|
2022 |
||
Net Sales |
$6,561 |
$7,212 |
$21,190 |
$16,946 |
||||
Cost of goods sold |
3,041 |
3,101 |
8,995 |
7,774 |
||||
Gross margin |
3,520 |
4,111 |
12,195 |
9,172 |
||||
Operating expenses: |
||||||||
Research and development |
1,577 |
1,432 |
4,922 |
4,605 |
||||
Selling, general and administrative |
2,006 |
1,967 |
7,003 |
5,943 |
||||
| Total operating expenses |
3,583 |
3,399 |
11,925 |
10,548 |
||||
| Operating income (loss) |
(63) |
712 |
270 |
(1,376) |
||||
| Non-operating income (loss): |
||||||||
| Interest income |
41 |
9 |
125 |
11 |
||||
| Gain on sale of assets |
- |
- |
- |
57 |
||||
| Foreign currency transaction gain (loss) |
(15) |
307 |
107 |
378 |
||||
| Total non-operating income (loss) |
26 |
316 |
232 |
446 |
||||
| Income (loss) before income taxes |
(37) |
1,028 |
502 |
(930) |
||||
| Income tax (expense) benefit |
(16) |
(181) |
(160) |
(700) |
||||
| Net income (loss) |
($53) |
$847 |
$342 |
($1,630) |
||||
| Basic earnings (loss) per share |
($0.01) |
$0.10 |
$0.04 |
($0.19) |
||||
| Diluted earnings (loss) per share |
($0.01) |
$0.10 |
$0.04 |
($0.19) |
||||
| Weighted-average basic shares |
9,020 |
8,816 |
8,914 |
8,715 |
||||
| Weighted-average diluted shares |
9,020 |
8,859 |
9,065 |
8,715 |
||||
| DATA I/O CORPORATION CONSOLIDATED BALANCE SHEETS (in thousands, except share data) (UNAUDITED) |
|||
|
September 30,
|
December 31,
|
||
| ASSETS |
|||
| CURRENT ASSETS: |
|||
| Cash and cash equivalents |
$11,867 |
$11,510 |
|
| Trade accounts receivable, net of allowance for |
|||
| doubtful accounts of $104 and $147, respectively |
4,900 |
4,992 |
|
| Inventories |
6,392 |
6,751 |
|
| Other current assets |
600 |
645 |
|
| TOTAL CURRENT ASSETS |
23,759 |
23,898 |
|
| Property, plant and equipment – net |
955 |
1,072 |
|
| Other assets |
1,602 |
2,195 |
|
| TOTAL ASSETS |
$26,316 |
$27,165 |
|
| LIABILITIES AND STOCKHOLDERS’ EQUITY |
|||
| CURRENT LIABILITIES: |
|||
| Accounts payable |
$1,101 |
$1,366 |
|
| Accrued compensation |
1,661 |
1,670 |
|
| Deferred revenue |
1,304 |
1,575 |
|
| Other accrued liabilities |
1,511 |
1,596 |
|
| Income taxes payable |
84 |
112 |
|
| TOTAL CURRENT LIABILITIES |
5,661 |
6,319 |
|
| Operating lease liabilities |
871 |
1,500 |
|
| Long-term other payables |
174 |
237 |
|
| COMMITMENTS |
- |
- |
|
| STOCKHOLDERS’ EQUITY |
|||
| Preferred stock - |
|||
| Authorized, 5,000,000 shares, including |
|||
| 200,000 shares of Series A Junior Participating |
|||
| Issued and outstanding, none |
- |
- |
|
| Common stock, at stated value - |
|||
| Authorized, 30,000,000 shares |
|||
| Issued and outstanding, 9,020,798 shares as of September 30, |
|||
| 2023 and 8,816,381 shares as of December 31, 2022 |
22,471 |
21,897 |
|
| Accumulated earnings (deficit) |
(2,789) |
(3,131) |
|
| Accumulated other comprehensive income |
(72) |
343 |
|
| TOTAL STOCKHOLDERS’ EQUITY |
19,610 |
19,109 |
|
| TOTAL LIABILITIES AND STOCKHOLDERS’ EQUITY |
$26,316 |
$27,165 |
|
| DATA I/O CORPORATION NON-GAAP FINANCIAL MEASURE RECONCILIATION |
||||||||
|
Three Months Ended
|
|
Nine Months Ended
|
||||||
| 2023 |
|
2022 |
|
2023 |
|
2022 |
||
| (in thousands) |
||||||||
| Net Income (loss) |
($53) |
$847 |
$342 |
($1,630) |
||||
| Interest (income) |
(41) |
(9) |
(125) |
(11) |
||||
| Taxes |
16 |
181 |
160 |
700 |
||||
| Depreciation and amortization |
180 |
148 |
468 |
441 |
||||
| EBITDA earnings (loss) |
$102 |
$1,167 |
$845 |
($500) |
||||
| Equity compensation |
300 |
264 |
929 |
935 |
||||
|
|
|
|
|
|||||
| Adjusted EBITDA, excluding equity compensation |
$402 |
$1,431 |
$1,774 |
$435 |
||||
